News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Belgium Recommends Merck & Co., Inc. and Sanofi-Aventis (France) HPV Vaccine for Girls
May 14, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Reuters) - Belgium has joined Austria, Germany, Italy, France, Norway and Luxemburg in recommending that girls be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc and Sanofi-Aventis SA in Europe.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Europe
Merck & Co.
Sanofi (France)
MORE ON THIS TOPIC
Multiple sclerosis
Immunic Talks Up Disability Gains as Phase II MS Therapy Fails on Primary Endpoint
May 1, 2025
·
2 min read
·
Tristan Manalac
Cancer
AACR 2025 Tracker: Marengo, BriaCell, Present Promising Data
April 30, 2025
·
8 min read
·
BioSpace Editorial Staff
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
April 30, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
April 29, 2025
·
2 min read
·
Tristan Manalac
